Implementation of guidelines on oxytocin use at caesarean section: a survey of practice in Great Britain and Ireland.
AffiliationAcademic Department of Obstetrics & Gynaecology, Coombe Women and Infants, University Hospital & Trinity College, University of Dublin, Dublin 8, Ireland., firstname.lastname@example.org
Oxytocics/*administration & dosage
Oxytocin/*administration & dosage
Practice Guidelines as Topic
MetadataShow full item record
CitationEur J Obstet Gynecol Reprod Biol. 2010 Feb;148(2):121-4. Epub 2009 Nov 6.
JournalEuropean journal of obstetrics, gynecology, and reproductive biology
AbstractOBJECTIVE: Caesarean section is one of the most commonly performed major operations on women worldwide. Operative morbidity includes haemorrhage, anaemia, blood transfusion and in severe cases, maternal death. Various clinical guidelines address oxytocin use at the time of caesarean section. We previously reported wide variation in practice amongst clinicians in the United Kingdom in the use of oxytocin at caesarean section. The aim of this current study was to determine whether the variation in approach is universal across the individual countries of Great Britain and Ireland and whether this reflects differences in interpretation and implementation of clinical practice guidelines. STUDY DESIGN: We conducted a survey of practice in the five individual countries of Great Britain and Ireland. A postal questionnaire was sent to all lead consultant obstetricians and anaesthetists with responsibility for the labour ward. We explored the use of oxytocin bolus and infusion, the measurement of blood loss at caesarean section and the rates of major haemorrhage. Existing clinical guidelines from the National Institute for Clinical Excellence (NICE), the Royal College of Obstetricians and Gynaecologists (RCOG) and ALSO (Advanced Life Support in Obstetrics) were used to benchmark reported practice against recommended practice for the management of blood loss at caesarean section. RESULTS: The response rate was 82% (391 respondents). Use of a 5 IU oxytocin bolus was reported by 346 respondents (85-95% for individual countries). In some countries, up to 14% used a 10 IU oxytocin bolus despite recommendations against this. Routine use of an oxytocin infusion varied greatly between countries (11% lowest-55% highest). Marked variations in choice of oxytocin regimens were noted with inconsistencies in the country-specific recommendations, e.g. NICE (which covers England and Wales) recommends a 30 IU oxytocin infusion over 4h, but only 122 clinicians (40%) used this. CONCLUSIONS: Clinicians' approach to the use of oxytocin at the time of caesarean delivery varies between countries. Even in countries with on-site visits to ensure guideline implementation (e.g. Clinical Negligence Scheme for Trusts in England), deviations from guideline recommendations exist. These variations may reflect a lack of robust evidence and the need for future research in this area.
- Use of oxytocin to prevent haemorrhage at caesarean section--a survey of practice in the United Kingdom.
- Authors: Wedisinghe L, Macleod M, Murphy DJ
- Issue date: 2008 Mar
- Study protocol. ECSSIT - Elective Caesarean Section Syntocinon Infusion Trial. A multi-centre randomised controlled trial of oxytocin (Syntocinon) 5 IU bolus and placebo infusion versus oxytocin 5 IU bolus and 40 IU infusion for the control of blood loss at elective caesarean section.
- Authors: Murphy DJ, Carey M, Montgomery AA, Sheehan SR, ECSSIT Study Group.
- Issue date: 2009 Aug 24
- An Australian and New Zealand survey of practice of the use of oxytocin at elective caesarean section.
- Authors: Mockler JC, Murphy DJ, Wallace EM
- Issue date: 2010 Feb
- A survey of anaesthetists on uterotonic usage practices for elective caesarean section in Australia and New Zealand.
- Authors: Terblanche NC, Otahal P, Sharman JE
- Issue date: 2021 Nov
- Impact of dose-finding studies on administration of oxytocin during caesarean section in the UK.
- Authors: West R, West S, Simons R, McGlennan A
- Issue date: 2013 Oct